NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
The figure was also narrower than the Zacks Consensus Estimate of a loss of 29 cents per share. Q2 Revenues Revenues totaled $19.3 million, up 16.9% year over year. The figure topped the Zacks Consensus Estimate by 2.9%. The revenue growth was driven by increased sales of the RNS System. Margins The gross profit in the reported quarter was $14.1 million, up 18.1% year over year. The gross margin expanded 89 basis points (bps) to 73.4% despite a 12.9% rise in the cost of sales. SG&A expenses declined 1.3% to $14.3 million. R&D expenses rose 13.5% to $6.1 million. The company registered an adjusted operating loss of $6.2 million in the second quarter compared with a loss of $7.9 million in the year-ago period. Financial Position NeuroPace exited the reported quarter with cash and cash equivalents of $12.8 million compared with $12.9 million at the end of the first quarter of 2024. Updated 2024 Guidance The company raised its revenue outlook for 2024. For the full y
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at JPMorgan Chase & Co. from $9.00 to $14.00. They now have an "overweight" rating on the stock.MarketBeat
- NeuroPace to Host Investor Day on January 28th in New York CityGlobeNewswire
- NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual MeetingGlobeNewswire
NPCE
Earnings
- 11/12/24 - Beat
NPCE
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/12/24 - Form 10-Q
- NPCE's page on the SEC website